AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Graftide-S 360 Tablet DR

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Mycophenolate sodium (360mg)

Overview Graftide-S 360 Tablet DR

Immunosuppressant medication, Graftide-S 360 Tablet DR, is administered post-transplant (kidney, heart, liver, etc.) to prevent organ rejection. Its mechanism involves immune system modulation, reducing the body's attack on the transplanted organ. Dosage is transplant-specific; strictly adhere to your physician's prescription. This medication can be taken with or without food; swallow whole – do not crush, chew, or break. Consistent use is crucial for optimal efficacy; discontinuation increases rejection risk. Treatment duration is determined by your need for rejection prevention. Common side effects include gastrointestinal upset (nausea, vomiting, diarrhea, stomach pain), headache, hypertension, and altered white blood cell counts. Immunosuppression increases infection susceptibility and cancer risk. A comprehensive list of potential side effects exists; consult your doctor regarding these and associated symptoms, as some necessitate immediate medical attention. Due to its potential to cause birth defects and miscarriage, avoid use during pregnancy, potential pregnancy, or breastfeeding. Prior to commencing treatment, inform your doctor of any infections, unusual bleeding or bruising, or pre-existing digestive issues. Complete disclosure of all other medications is essential due to potential drug interactions. Regular blood tests will monitor blood cell counts; report any unexplained bruising/bleeding, sore throat, mouth sores, or fever immediately.

Primary Ingredients of Graftide-S 360 Tablet DR

No text was provided to rewrite.

Uses of Graftide-S 360 Tablet DR

Preventing graft rejection after organ transplantation

Major Benefits of Graftide-S 360 Tablet DR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Graftide-S 360 Tablet DR whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.

Common Side effects of Graftide-S 360 Tablet DR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • High blood pressure
  • Decreased white blood cell count (neutrophils)
  • Bacterial infection
  • Fungal infection
  • Pneumonia
  • Increased uric acid level in blood
  • Electrolyte imbalance
  • Anxiety
  • Breathlessness
  • Increased creatinine level in blood
  • Anemia (low number of red blood cells)
  • Acne
  • Muscle pain

How to use Graftide-S 360 Tablet DR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Graftide-S 360 Tablet DR. Ingest the tablet whole; do not chew, crush, or divide it. This medication can be administered with or without food, though consistent timing is recommended.

How Graftide-S 360 Tablet DR works:

Graftide-S 360 DR tablets function as an immunosuppressant, mitigating the body's immune response to prevent organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholSAFE

Alcohol consumption alongside Graftide-S 360 Tablet DR presents no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Graftide-S 360 Tablet DR during pregnancy poses a confirmed risk to the fetus. Prescribing it may be considered only in exceptional, life-threatening circumstances where potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

The use of Graftide-S 360 Tablet DR is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingSAFE

Driving ability is typically unaffected by Graftide-S 360 Tablet DR.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Graftide-S 360 Tablet DR. Dosage modification of Graftide-S 360 Tablet DR may be necessary. Physician consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

The use of Graftide-S 360 Tablet DR in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary for this patient population. Physician consultation is advised.

What if you forget to take Graftide-S 360 Tablet DR :

Should you forget a Graftide-S 360 Tablet DR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Graftide-S 360 Tablet DR

LabelValue
Chemical Category Phthalide-based compound
Developing Habits No.
Type of Treatment Cancer Medications
Behavior Class Purine analog immunosuppressants

FAQs on Graftide-S 360 Tablet DR

Graftide-S 360 Tablet DR is an immunosuppressant medication prescribed to help your body accept your transplanted kidney. It achieves this by suppressing your immune system's rejection of the foreign organ.
Graftide-S 360 Tablet DR may increase the risk of skin cancer and lymphoma. Minimize sun exposure by wearing protective clothing and sunscreen when outdoors. Consult your doctor if you develop any new skin lesions, changes in existing moles, unusual sores, persistent skin changes, non-healing sores, unexplained fever, fatigue, weight loss, or swollen lymph nodes (neck, groin, or armpits).
Graftide-S 360 Tablet DR is a non-steroidal, non-chemotherapy immunosuppressant. It works by suppressing the immune system to prevent organ rejection. Hair loss is a common side effect.
To monitor your blood and organ function while taking Graftide-S 360 Tablet DR (as it can affect blood counts, kidneys, and liver), your doctor will order blood tests before and during treatment. These regular checks help assess your response to the medication and detect any side effects.
Graftide-S 360 Tablet DR suppresses your immune system. Because your immunity is already compromised, exposure to chicken pox or shingles poses a significant risk of infection. Your doctor's caution is crucial; contact them immediately if you develop either illness, as specialized care may be necessary.
Avoid Graftide-S 360 Tablet DR if pregnant or planning pregnancy. First-trimester use carries a high risk of miscarriage and birth defects. Therefore, use two reliable forms of contraception concurrently for four weeks before treatment, throughout treatment, and for six weeks afterward. Your doctor will recommend suitable methods. Note that Graftide-S 360 Tablet DR can reduce the effectiveness of birth control pills, necessitating a second form of contraception.
Reliable contraception should be used by either the man or his partner throughout treatment and for 90 days afterward. Men should refrain from donating semen during and for 90 days after Graftide-S 360 Tablet DR treatment.
Graftide-S 360 Tablet DR
980